دواعي استعمال Rocephin 500 mg i.v. vial

Ceftriaxone 500 mg powder for intravenous injection, single vial (Rocephin brand manufactured in Egypt by EIPICO).

• Lower respiratory tract infections caused by susceptible organisms.DailyMed (U.S. National Library of Medicine)
• Acute bacterial otitis media.DailyMed (U.S. National Library of Medicine)
• Skin and skin structure infections.DailyMed (U.S. National Library of Medicine)
• Urinary tract infections.DailyMed (U.S. National Library of Medicine)
• Uncomplicated gonorrhoea.DailyMed (U.S. National Library of Medicine)
• Pelvic inflammatory disease.DailyMed (U.S. National Library of Medicine)
• Bacterial septicaemia.DailyMed (U.S. National Library of Medicine)
• Bone and joint infections.DailyMed (U.S. National Library of Medicine)
• Intra-abdominal infections.DailyMed (U.S. National Library of Medicine)
• Meningitis.DailyMed (U.S. National Library of Medicine)
• Surgical prophylaxis.DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to ceftriaxone, any excipient or any other cephalosporin.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Premature neonates up to a postmenstrual age of 41 weeks, and hyperbilirubinaemic neonates.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Neonates (28 days or younger) who require or are expected to require calcium-containing IV solutions, because of ceftriaxone-calcium precipitation.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Serious, occasionally fatal hypersensitivity reactions (anaphylaxis); use cautiously in patients allergic to penicillins or other beta-lactams.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Ceftriaxone-calcium precipitation with calcium-containing solutions; fatal cases in neonates have been reported.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Serious neurological adverse reactions (encephalopathy, seizures, myoclonus, non-convulsive status epilepticus), some in severe renal impairment.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Calcium-containing IV solutionsRisk of ceftriaxone-calcium precipitation; must not be mixed or given simultaneously; contraindicated in neonates.DailyMed (U.S. National Library of Medicine)

• No embryotoxicity or teratogenicity in animal studies; no adequate well-controlled studies in pregnant women; use only if clearly needed.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• Low concentrations are excreted in human milk; use with caution in nursing women.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)